MH Stock Analysis: McGraw Hill | NYSE
Education & Training Services | NYSE, USA | Market Cap: 2.219m USD | 12M Return: -4% | US5809071039 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.20M
Qual. Beats: 0
Rev. Trend: 94.9%
Warnings
Tailwinds
Seasonality 1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
McGraw Hill, Inc. is a U.S.-based educational content and learning solutions provider operating through four reportable segments: K-12, Higher Education, Global Professional, and International. The company delivers core, supplemental, and adaptive learning materials to school districts, higher education institutions, and individual learners across the United States and abroad.
The K-12 and Higher Education segments target the U.S. market, distributing through direct sales to school districts, distribution partners, online retailers, and the companys proprietary e-commerce platform. The Global Professional segment serves medical and engineering learners, while the International segment extends the companys footprint to approximately 100 countries and 80 languages.
Founded in 1888 and headquartered in Columbus, Ohio, McGraw Hill was formerly known as Mav Holding Corporation before adopting its current name in October 2022. The company completed its IPO in July 2025 and operates as a subsidiary of Pe Mav Holdings, LLC. The broader education publishing industry has been shifting from print-based delivery toward digital, subscription-based, and adaptive learning models, a transition reflected in McGraw Hills blended digital-and-print product portfolio.
- K-12 state funding cycles shape curriculum adoption demand
- Higher education enrollment decline pressures textbook and digital revenue
- Digital transition expands segment margins as legacy print contracts
- Competition with Pearson and Cengage intensifies in education publishing
| Net Income: 35.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.19 > 1.0 |
| NWC/Revenue: -13.93% < 20% (prev -13.22%; Δ -0.71% < -1%) |
| CFO/TA 0.06 > 3% & CFO 331.2m > Net Income 35.3m |
| Net Debt (2.46b) to EBITDA (643.2m): 3.83 < 3 |
| Current Ratio: 0.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (187.3m) vs 12m ago -1.92% < -2% |
| Gross Margin: 80.92% > 18% (prev 79.90%; Δ 1.02% > 0.5%) |
| Asset Turnover: 37.41% > 50% (prev 36.50%; Δ 0.91% > 0%) |
| Interest Coverage Ratio: 1.47 > 6 (EBIT TTM 303.9m / Interest Expense TTM 207.2m) |
| A: -0.05 (Total Current Assets 973.6m - Total Current Liabilities 1.27b) / Total Assets 5.49b |
| B: -0.23 (Retained Earnings -1.25b / Total Assets 5.49b) |
| C: 0.05 (EBIT TTM 303.9m / Avg Total Assets 5.62b) |
| D: 0.15 (Book Value of Equity 726.2m / Total Liabilities 4.76b) |
| Altman-Z'' = -0.57 = B |
| DSRI: 1.07 (Receivables 362.5m/338.4m, Revenue 2.10b/2.10b) |
| GMI: 0.99 (GM 79.90% / 80.92%) |
| AQI: 1.01 (AQ_t 0.80 / AQ_t-1 0.79) |
| SGI: 1.00 (Revenue 2.10b / 2.10b) |
| TATA: -0.05 (NI 35.3m - CFO 331.2m) / TA 5.49b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of August 14, 2026, the stock is trading at USD 13.57 with a total of 1,809,175 shares traded. Over the past week, the price has changed by +17.49%, over one month by +28.99%, over three months by +17.39% and over the past year by -3.96%.
Current recommended Stop Loss: 12.50 (which is 7.9% or 1.8 ATR below the current price).
McGraw Hill has no consensus analysts rating.
P/E Trailing = 61.0526
P/E Forward = 9.4967
P/S = 1.0552
P/B = 3.0606
Revenue TTM = 2.10b USD
EBIT TTM = 303.9m USD
EBITDA TTM = 643.2m USD
Long Term Debt = 2.56b USD (from longTermDebt, last quarter)
Short Term Debt = 27.7m USD (from shortTermDebt, last quarter)
Debt = 2.72b USD (from shortLongTermDebtTotal, last quarter) + Leases 71.8m
Net Debt = 2.46b USD (calculated: Debt 2.72b - CCE 253.5m)
Enterprise Value = 4.68b USD (2.22b + Debt 2.72b - CCE 253.5m)
Interest Coverage Ratio = 1.47 (Ebit TTM 303.9m / Interest Expense TTM 207.2m)
EV/FCF = 17.40x (Enterprise Value 4.68b / FCF TTM 269.1m)
FCF Yield = 5.75% (FCF TTM 269.1m / Enterprise Value 4.68b)
FCF Margin = 12.80% (FCF TTM 269.1m / Revenue TTM 2.10b)
Net Margin = 1.68% (Net Income TTM 35.3m / Revenue TTM 2.10b)
Gross Margin = 80.92% ((Revenue TTM 2.10b - Cost of Revenue TTM 401.1m) / Revenue TTM)
Gross Margin QoQ = 83.86% (prev 85.29%)
Tobins Q-Ratio = 0.85 (Enterprise Value 4.68b / Total Assets 5.49b)
Interest Expense / Debt = 7.63% (Interest Expense 207.2m / Debt 2.72b)
Taxrate = 19.34% (8.47m / 43.8m)
NOPAT = 245.1m (EBIT 303.9m * (1 - 19.34%))
Current Ratio = 0.77 (Total Current Assets 973.6m / Total Current Liabilities 1.27b)
Debt / Equity = 3.74 (Debt 2.72b / totalStockholderEquity, last quarter 726.2m)
Debt / EBITDA = 3.83 (Net Debt 2.46b / EBITDA 643.2m)
Debt / FCF = 9.16 (Net Debt 2.46b / FCF TTM 269.1m)
Total Stockholder Equity = 644.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.63% (Net Income 35.3m / Total Assets 5.49b)
RoE = 5.48% (Net Income TTM 35.3m / Total Stockholder Equity 644.9m)
RoCE = 9.48% (EBIT 303.9m / Capital Employed (Equity 644.9m + L.T.Debt 2.56b))
RoIC = 5.92% (NOPAT 245.1m / Invested Capital 4.14b)
WACC = 3.39% (E(2.22b)/V(4.94b) * Re(0.0%) + D(2.72b)/V(4.94b) * Rd(7.63%) * (1-Tc(0.19)))
Discount Rate = 5.29% (= Risk Free + ERP)
Shares (quarterly) Correlation: -52.22 | Cagr: -0.86%
[DCF] Terminal Value 73.10% ; FCFF base≈370.9m ; Y1≈325.3m ; Y5≈262.8m
[DCF] Fair Price = 9.17 (EV 4.22b - Net Debt 2.46b = Equity 1.75b / Shares 191.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.14 | # QB: 0
Revenue Correlation: 94.92 | Revenue CAGR: 3.86% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.48 | Chg30d=+0.00% | Revisions=+36% | Analysts=12
EPS next Quarter (2026-09-30): EPS=0.83 | Chg30d=+0.00% | Revisions=+36% | Analysts=12
EPS current Year (2027-03-31): EPS=1.95 | Chg30d=+0.00% | Revisions=+69% | GrowthEPS=-4.2% | GrowthRev=+2.2%
EPS next Year (2028-03-31): EPS=2.04 | Chg30d=+6.01% | Revisions=+50% | GrowthEPS=+4.5% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +60% (up=33, down=7)